11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 8 USDMF, 1 EU WC, 8 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 26 FDA Orange Book, 17 Europe, 2 Canada, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05%, OINTMENT;TOPICAL - 0.05%, GEL;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 DKSH, 1 Faran Shimi Pharmaceutical, 6 Nanjing Well Pharmaceutical, 4 Actylis, 19 BASF, 1 Finar, 4 Gangwal Chemicals, 6 Kerry, 4 Microlex e.U, 2 Pluviaendo, 4 Roquette, 5 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical, 13 Solubilizers, 11 Emulsifying Agents, 9 Film Formers & Plasticizers, 9 Coating Systems & Additives, 8 Thickeners and Stabilizers, 8 Surfactant & Foaming Agents, 6 Parenteral, 6 Lubricants & Glidants, 5 Granulation, 5 Co-Processed Excipients, 4 Fillers, Diluents & Binders, 3 Direct Compression, 2 Taste Masking, 2 Controlled & Modified Release, 1 API Stability Enhancers